PEOPLE - Neoprobe (US) announces new appointments:
This article was originally published in Clinica
Executive Summary
Neoprobe (US) has announced some new appointments. Louis Cosentino has joined the company as vice-president of marketing and corporate development. He was formerly vice-president of advanced concepts and technology with Ethicon Endo-Surgery. Dana Thomas is named director of global distribution. He was formerly senior marketing manager at Mallinckrodt Medical. James Carni has joined as director of process development. He has had considerable experience in the pharmaceutical industry. Dale Slifko is appointed project manager of instruments, having formerly held a similar position at Progenics.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.